IISc Gets New CoE in Ayurveda; MoA to Grant INR 52.47 Crore to Establish Six New Centres of Excellence

On the occasion of the 9th National Ayurveda Day, the ministry announced the launch of six new centres of Excellence in Ayurveda in institutions like IISc, IIT Delhi, JNU, CSIR Lucknow, and so on. 

The Prime Minister of India Narendra Modi has launched a Centre of Excellence in Ayurveda at the Indian Institute of Science (IISc). The announcement has been made coinciding with the 9th National Ayurveda Day with the theme 'Ayurveda Innovations for Global Health'. This year the theme was based on integrating Ayurveda with modern science and focusing on critical health like diabetes. 

On the occasion of National Ayurveda Day 2024, another highlight was the launch of six new centres of Excellence in Ayurveda in institutions like IISc, IIT Delhi, JNU, CSIR Lucknow, and others. The Ministry of AYUSH will grant INR 52.47 crore to the new centres in order to enhance cutting-edge research options, incline towards education and healthcare innovation in the field of Ayurveda by offering scientific underpinning for traditional knowledge. 

Diabetes Needs Attention 

Diabetes has become a global health crisis. The modern allopathic medicine offers effective treatments, the Ayurveda has evolved as an alternative approach without side effects. This ancient system seeks to offer prevention, lifestyle adjustments, and natural remedies for complete diabetes management. In order to achieve these goals, the Centre of Excellence will cooperate with institutions with expertise in Ayurveda, diabetes, and medical research. These collaborations will promote interdisciplinary research, understanding, and the translation of research for the betterment of real-world clinical practice.

Besides, a randomised active comparator-controlled clinical trial will take place that will be infused with a longitudinal study over two years, to evaluate the usefulness of two new Ayurvedic formulations (Mustadi Ghana Vati and Varadi Ghana Vati) in prediabetes and Type II diabetes. The authorities have started the enrollment of the subjects as the due processes of ethics committee approval, registration of study on the Clinical Trial Registry of India (CTRI), and constitution of the Data Safety Monitoring Board (DSMB) have been duly taken. 

Read more:

• DU SOL Admission 2024 Ongoing Till Oct 31; Over One Lakh Applications Received
• RUHS BSc Nursing Counselling 2024 Round 1 Seat Allotment Result Today